FUNI

PINK Hypha Labs, Inc.
Oct 26, 2026 · 7:36 AM ET EOD Market Closed

$0.0045 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.0045, and at the day’s high of $0.0045

YTD change
-88.75%
vs 20-day SMA
+2.28%
vs 200-day SMA
-78.93%

Price ranges

Previous day
$0.0044 $0.0045
open $0.0044 close $0.0045
+$0.0002 (+3.45%)
Today
$0.0044 $0.0045
$0.0045
Past week
$0.0040 $0.0045
from $0.0042 now $0.0045
+$0.0003 (+7.14%)
Past month
$0.0039 $0.0060
from $0.0060 now $0.0045
-$0.0015 (-25.00%)
This year
$0.0023 $0.0400
from $0.0400 now $0.0045
-$0.0355 (-88.75%)

Price & Performance

-0.02 (-80.52%) / 6M

$0.0020$0.0115$0.0210$0.0305Apr 27Jul 21Oct 23

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 92.5% away from all-time highs of $0.0600
  • FUNI is down 89% since the beginning of the year
  • FUNI is down 84% over the past 12 months
  • FUNI is down 25% over the past 1 month

FUNI reads neutral: price sits above one of the two key moving averages, the 12-month move is -83.5%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.0019
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Enterprise value $2.8M
Beta 2.14

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$5.1K
Debt$1.8K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangePINK
Market cap $737.5K

Hypha Labs, Inc. engages in the research, development, and commercialization of a bioreactor. The firm bioreactor is a home appliance designed to accelerate the production of functional mushrooms. The company was founded on October 5, 2010 and is headquartered in Las Vegas, NV.

Competitor comparison

No peer group available for this symbol.

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.